Orthopedics Medical News about Renal Function

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cystatin C a Marker for Renal Function after Exercise
International Journal of Sports Medicine, 08/17/09

Mingels A et al. – Renal function is evaluated using serum creatinine, urine parameters, and equations to estimate the Glomular Filtration Rate (GFR). The mean cystatin C increase was twice as low as compared to creatinine (21% and 41%, respectively), suggesting that cystatin C is indeed less biased by muscle damage.

<< Previous
Multimodal Therapy for Vertebral Involvement of Systemic...

Next >>
Tensile strength of superior labral repairs in the throwing...

Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations, 11/19/09 Relevance Score: 69%

Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome
Clinical Journal of the American Society of Nephrology, 11/13/09 Relevance Score: 69%

Value of serum cystatin C as a marker of renal function in the early post kidney transplant period
Saudi Journal of Kidney Diseases and Transplantation, 11/02/09 Relevance Score: 69%

VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III Vista study
Journal of Clinical Oncology, 10/29/09 Relevance Score: 69%

Recoverability of Renal Function After Relief of Chronic Partial Unilateral Ureteral Obstruction: Study of the Effect of Angiotensin Receptor Blocker (Losartan)
Urology, 10/28/09 Relevance Score: 69%